Abstract:Introduction: Malignant Peritoneal Mesothelioma (MPM) is a rare and aggressive intra-abdominal neoplasm originating from mesothelial cells. Although asbestos exposure is a known risk factor, MPM's molecular pathogenesis differs from its pleural counterpart. Case Presentation: A 75-year-old male, with a past medical history of recently diagnosed mesothelioma, presented to the emergency department for a two-week progression of abdominal distension, early satiety, and dyspnea aggravated by activity. One year prior, he initiated medical evaluation for fluid retention and abdominal distension. A recent omental biopsy confirmed the diagnosis of mesothelioma, prompting the initiation of chemotherapy every three weeks. Despite paracentesis performed monthly, the patient experienced worsening shortness of breath and early satiety post-chemotherapy. Discussion: Malignant Peritoneal Mesothelioma poses a diagnostic challenge due to the absence of specific signs or symptoms. Common manifestations include abdominal distension, pain, early satiety, weight loss, dyspnea, chest pain, and fatigue. Rare symptoms encompass new-onset hernia, fever of unknown origin, night sweats, or incidental findings during physical examinations or laparoscopy. Delays in presentation and diagnosis contribute to the advanced stage at diagnosis, with most cases having already spread throughout the abdominal cavity. Three distinct presentations of MPM include the Dry Painful Type, characterized by abdominal pain with minimal ascites; the Wet Type, presenting with abdominal distension and ascites; and the Mixed Type, combining abdominal pain and distension. Paraneoplastic phenomena, such as fever, thrombocytosis, malignancy-related thrombosis, hypoglycemia, hypoalbuminemia, paraneoplastic hepatopathy, and rarely, Coombs-positive Hemolytic anemia, further complicate the clinical picture. Surgical gross and microscopic descriptions of liver biopsies indicated chronic hepatitis with mild portal inflammation, grade 1, and no fibrosis, stage 0. Notably, the omental biopsy confirmed Malignant Mesothelioma of the epithelioid type. Immunohistochemical stains supported the diagnosis, revealing positivity for CK AE1/AE3, calretinin, WT1, CK7 (focally), and GATA3 (focally), while testing negative for BAP1, CDX2, chromogranin, CK20, hepatocyte antigen, PAX8, PSA, synaptophysin, and TTF1. Due to the rarity of MPM, no standardized treatment protocols exist. Cytoreductive surgery (CRS) and hyperthermic intraoperative peritoneal perfusion with chemotherapy (HIPEC) are recommended for selected patients without extraperitoneal disease spread, possessing a good performance status and potential for complete surgical cytoreduction. Systemic chemotherapy, particularly pemetrexed-based regimens, is advocated for patients ineligible for CRS/HIPEC. Conclusion: MPM's aggressive nature poses diagnostic and therapeutic challenges. The scarcity of standardized guidelines emphasizes the importance of ongoing research to enhance understanding, improve diagnostics, and develop targeted therapies Citation Format: Aliya M Khan, Mehmet Hepgur, Aryama Sharma. Unraveling the complexity of malignant peritoneal mesothelioma: A comprehensive case study of diagnosis, clinical features, and therapeutic challenges in a 75-year-old male [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr C069.

Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly

Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.

Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome

Malignant Peritoneal Mesothelioma Presenting with Persistent High Fever.

Clinical features and prognosis-related factors of mantle cell lymphoma in elderly patients

Abstract C069: Unraveling the complexity of malignant peritoneal mesothelioma: A comprehensive case study of diagnosis, clinical features, and therapeutic challenges in a 75-year-old male

Laparoscopic Pancreaticodoudenectomy an Excellent Approach in Elderly Patients, a Multicenter, Comparative Study

[Analysis of clinicopathological features of 68 cases of malignant pleural mesothelioma]

[Prognosis Related Clinical and Molecular Factors in Malignant Pleural Mesothelioma].

Prognostic significance of inflammation-related and electrolyte laboratory variables in patients with malignant pleural mesothelioma

Prognostic Factors and Treatment Strategies for Elderly Patients with Malignant Meningioma: A SEER Population-Based Study

Clinical and pathological observation of conversion therapy for malignant peritoneal mesothelioma: a case report and literature review

Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report

[Advances in Immunotherapy for Malignant Pleural Mesothelioma].

Prognosis and role of clinical and imaging features in patients with malignant pericardial effusion: a single-center study in China

Clinical Features and Treatment Principles of Malignant Tumors in the Elderly

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma

Case report: Quadruple primary malignant neoplasms including esophageal, ureteral, and lung in an elderly male

Advanced or metastatic gastric cancer in elderly patients: clinicopathological, prognostic factors and treatments

Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma